Key points are not available for this paper at this time.
Abstract Background Older patients typically face elevated mortality rates and greater medical resource utilization during hospitalizations compared to their younger counterparts. Sarcopenia, serving as a prognostic indicator, is related to disability, diminished quality of life, and increased mortality. The SARC-F questionnaire, known for its cost-effectiveness, offers a valuable means of assessing sarcopenia. Method Participants aged 60 and above, admitted to the Cardiovascular Department from November 2021 to June 2022, were recruited in the prospective, single-center study. The prognostic outcomes included all-cause death and the initial occurrence of emergency rehospitalization within six months’ post-discharge. The Kaplan–Meier analysis compared the overall survival rates between different SARC-F score groups. Results The study enrolled 285 patients with a median age of 74 (67, 81). During a 6-month follow-up period, there were 14 cases of mortality. A SARC-F score of 4 or higher was significantly associated with an increased risk of all-cause mortality, with HR of 2.02 (95% CI: 1.39 – 2.92, p < 0.001), and higher incidence of re-hospitalization events with RR of 1.66 (95% CI: 1.06 to 2.59, p = 0.026). Kaplan-Meier survival analysis indicated a notably higher mortality rate in the patients with high SARC-F scores (p < 0.001). Conclusions In elderly patientswith cardiovascular disease, the SARC-F questionnaire could serve as a simple and cost-effective method for detecting mortality and the risk of rehospitalization.
Nguyen et al. (Tue,) studied this question.